(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)

Modify Date: 2024-01-02 08:15:02

(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) Structure
(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) structure
Common Name (R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)
CAS Number 176763-62-5 Molecular Weight 605.759
Density N/A Boiling Point N/A
Molecular Formula C36H52CoN2O2 Melting Point >350ºC(lit.)
MSDS Chinese USA Flash Point N/A
Symbol GHS07
GHS07
Signal Word Warning

 Names

Name (R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)
Synonym More Synonyms

 Chemical & Physical Properties

Melting Point >350ºC(lit.)
Molecular Formula C36H52CoN2O2
Molecular Weight 605.759
Exact Mass 605.351746
PSA 43.18000
LogP 8.28320

 MSDS


Section 1: Product Identification
Chemical Name:(1R,2R)-(-)-1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)cobalt (II)
CAS Registry Number:176763-62-5
Formula:C36H52CoN2O2
EINECS Number:none
Chemical Family:organometallic complexes
Synonym:none

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound176763-62-5100%0.02mg/m3 (as Co)no data

Section 3: Hazards Identification
Causes irritation of eyes, skin, and respiratory tract. May cause lung disease, polycythemia, congestive failure,
Emergency Overview:
and enlargement of the thyroid. Limited evidence of a carcinogenic effect.
Primary Routes of Exposure:Skin and eyes, ingestion and dust inhalation.
Eye Contact:Causes irritation, redness, and pain.
Skin Contact:May cause dermatitis. Causes irritation to skin. Symptoms include redness, itching, and pain.
Causes irritation to the respiratory tract. Symptoms may include coughing, shortness of breath, nausea,
Inhalation:
respiratory hypersensitivity, asthma.
Causes abdominal pain, nausea, vomiting, flushing of the face and ears, mild hypo tension, rash, and ringing
Ingestion:
in the ears.
Irritating to skin, eyes and respiratory tract. Causes abdominal pain, nausea, vomiting, coughing, and
Acute Health Affects:
shortness of breath.
Repeated oral administration of cobalt salts may reduce thyroid activity, cause blood disease, and damage
Chronic Health Affects:kidney, heart and lungs. Prolonged or repeated skin exposure may cause dermatitis. Limited evidence of a
carcinogenic effect.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:not applicable
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:carbon dioxide, foam or dry powder
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self- contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit toxic organic fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Small spills can be mixed with vermiculite, sodium carbonate or other suitable non combustible adsorbent and
Spill and Leak Procedures:
swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a tightly sealed container away from heat and direct sunlight.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:red-brown pwdr.
Molecular Weight:603.76
Melting Point:406-412°C
Boiling Point:no data
Vapor Pressure:not applicable
Specific Gravity:no data
Odor:none
Solubility in Water:insoluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:oxidizing agents
Decomposition Products:carbon dioxide, carbon monoxide, nitrogen oxides, organic fumes, and cobalt oxide.

SECTION 11: Toxicological Information
RTECS Data:No information available in the RTECS files.
Carcinogenic Effects:Possible carcinogen
Mutagenic Effects:No data
Tetratogenic Effects:No data

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Not listed in the TSCA inventory.
SARA (Title 313):Title compound: See category N096 for reporting.
Second Ingredient:None


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H302-H312-H332
Precautionary Statements P280
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xn: Harmful;
Risk Phrases R20/21/22
Safety Phrases 36/37/39
RIDADR NONH for all modes of transport
WGK Germany 3

 Articles2

More Articles
Asymmetric catalysis with water: efficient kinetic resolution of terminal epoxides by means of catalytic hydrolysis.

Science 277 , 936, (1997)

Epoxides are versatile building blocks for organic synthesis. However, terminal epoxides are arguably the most important subclass of these compounds, and no general and practical method exists for the...

Jacobsen, E.N. et al.

Tetrahedron Lett. 38 , 773, (1997)

 Synonyms

2,2'-{(1R,2R)-1,2-Cyclohexanediylbis[nitrilo(E)methylylidene]}bis[4,6-bis(2-methyl-2-propanyl)phenol] - cobalt (1:1)
(R,R)-(-)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)
Phenol, 2,2'-[(1R,2R)-1,2-cyclohexanediylbis[nitrilo(E)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)-, cobalt salt (1:1)
MFCD01631277
(R,R)-(-)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINO-COBALT(II)
Top Suppliers:I want be here



Get all suppliers and price by the below link:

(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) suppliers


Price: ¥37/250mg

Reference only. check more (R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) price